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 Abstract
Routine sources of data provide limited information on 
aetiological agents causing infectious intestinal disease (IID) in 
the community.  A retrospective, age-stratified, cross-sectional, 
telephone study at community level was performed whereby 
identified cases were asked to submit stools for analysis.
Of a total of 3504 persons who participated, 99 respondents 
were suffering from IID.  Of these, 37.4% (n=37) cases submitted 
stools for analysis.  These samples were analysed for bacteria 
(Salmonella, Campylobacter, Escherichia coli, Shigella), 
protozoa and viruses (rotavirus, norovirus).
Salmonella goldcoast was identified in 2.7% (n=1 of 37 
tested) of cases, rotavirus in 10% (n=3 of 30 tested) of cases 
and norovirus in 20% (n=6 of 30 tested) of cases. 
This study describes norovirus being the commonest 
aetiological cause of IID in the community of Malta, which along 
with the data from the national surveillance system is of value in 
planning policies for the control of infectious intestinal disease. 
Introduction
Infectious intestinal disease (IID) is still one of the 
commonest infectious diseases.1-2 However, data on the 
pathogens causing IID is limited mainly to routine laboratory-
based surveillance. In Malta, a small island state, the Infectious 
Disease Prevention and Control Unit within the Health 
Promotion and Disease Prevention Directorate, is responsible 
for the surveillance of infectious intestinal disease. This unit 
receives notifications from general practitioners, hospital 
physicians and laboratories. The majority of notifications 
received include cases that required hospitalisation or referral 
for stool culture analysis. Therefore, it is only a small proportion 
of the actual cases occurring in the community which are actually 
tested to identify the aetiological pathogen as is illustrated in 
Figure 1, which represents the reporting pyramid for IID in 
Malta. 
From the current laboratory based surveillance system, 
the commonest pathogens identified are Campylobacter, 
Salmonella, E. coli (generic), and a minority of cases of 
shigellosis, giardiasis, and cryptosporidiosis. A substantial 
number of notified cases are defined as unspecified where the 
aetiological agent has not been identified (Table 1).3   For the 
unspecified cases, the pathogen may have not been isolated 
from the specimens or, it may have been a pathogen that was 
not tested for, or it is one which has not yet been identified. It 
may well be that the majority of these cases are of viral origin, 
since tests for viruses are not routinely carried out in Malta 
unless specifically requested. 
The overall trend in bacterial pathogens over recent years 
in Malta is that of a statistically significant increase (p<0.01) in 
the incidence of campylobacter cases (Figure 2).3
A number of studies have been performed in various 
countries to identify the common microbiological causes of IID, 
going beyond the information obtained from routine sources.4-8 
In England, population-based cohorts were recruited from 
practice lists and followed up whilst a nested, case-control, 
general practitioner (GP) component was carried out. These 
identified micro-organisms associated with IID at community 
and GP level.4 In the Netherlands, cases of gastroenteritis that 
had consulted a GP and cases from a community-based study 
were asked to submit stools for pathogen identification.5,6 
Subsequently, a one-year intensified retrospective study 
of outbreaks of gastroenteritis was carried out to identify 
the causative pathogens.7 Sweden embarked on a one-year 
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prospective study to identify entero-pathogens in cases of 
diarrhoea.8 From these studies, the commonest pathogen 
identified at community level was norovirus and, at GP level, 
campylobacter (Table 2).
To date there are no known studies in Malta that have 
attempted to define the relative contributions of different entero-
pathogenic bacteria, protozoa and viruses causing IID in the 
community. This study was conducted as part of a coordinated 
series of studies on IID that were initiated in 2003.9-11 This paper 
describes the main microbiological findings of this study.
Methods
A retrospective, age-stratified, cross-sectional, telephone 
study was carried out in order to define the relative contribution 
of the various pathogens at community level. A random sample of 
3513 persons from the community of Malta was interviewed by 
means of a structured questionnaire between April 2004 and 
December 2005.10 Participants were asked about symptoms 
of infectious intestinal disease and were defined as cases or 
non cases based on the following case definitions:
Case definition for cases
Inclusion criteria: individuals who reported at least three 
episodes of diarrhoea (defined as loose stools) within 24 
hours or vomiting at least three times in 24 hours, or suffered 
diarrhoea or vomiting with two or more additional symptoms 
in 24 hours, over the previous 28 days. Additional symptoms 
sought included abdominal cramps, abdominal pain, fever, 
nausea, blood in stools or mucus in stools. 
Exclusion criteria: individuals reporting any pre-existing 
illness or non-infectious conditions diagnosed by a medical 
doctor in which vomiting/diarrhoea was a symptom, or who 
were concurrently taking any medications which could cause 
diarrhoea/vomiting as side effects. This definition was chosen 
from the case definitions available from literature5,12-15 and was 
adapted for the study for Malta.
The persons were interviewed by trained health personnel 
working in the field of public health and identified cases 
were asked to submit stool or vomitus, according to the 
predominant symptom, for analysis in order to attempt 
identification of the aetiological agent. The appropriate 
forms and sample bottles were delivered on the same day 
that the case was interviewed by health personnel. Collection 
by health personnel was offered if the case was too sick (to 
do so) or had other problems in delivering the sample to 
the laboratory. Testing for bacteria, viruses and parasites 
was performed on the samples. The target pathogens were 
chosen based on known predominant types from routine 
surveillance. Samples were analysed at the local Microbiology 
Department for Salmonella, Campylobacter, Shigella, E. coli 
and rotavirus. Testing for noroviruses was performed at the 
Istituto Superiore di Sanita` (ISS) in Rome. Stool suspensions 
Figure 1:  Reporting fractions of IID in Malta








Exposures in the general population
Table 1:  National surveillance of IID in Maltese residents: 
number of cases reported during 2010 through the national reporting system
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Figure 2: Reported sporadic foodborne illness to national surveillance in Malta, 1992-2010, by aetiological agent.
Table 2: Percentage of identified pathogens of IID from international studies



















Campylobacter spp. 12.2 10.4 13.0 1.7 4.2 2.0
Escherichia coli 0157 0.1 0.5 8.0 0 0 <1.0
Salmonella spp. 5.0 3.9 7.0 4.0 1.1 4.0
Shigella spp. 0.8 0.1 4.0 0.5 0.1 <1.0
Protozoa
Cryptosporidium 1.3 2.1 2.0 0.5 0.4 2.0
Giardia 1.0 5.4 2.0 0.5 0.4 5.0
Viruses
Rotavirus 6.7 5.3 3.0 2.0 4.3 4.0
Norovirus 6.5 5.1 3.0 54.0 7.0 11.0
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were prepared in Malta and samples were batched and stored 
at –80°C until delivery to ISS.
Laboratory methods for testing
The fresh stool samples were suspended in saline. This 
suspension was inoculated on commercial and differential 
culture media as well as in salinide and Campylobacter broth. 
After incubation for 3 days at 37°C, the samples were plated 
on Salmonella/Shigella agar for detection of Salmonella 
and Shigella species on days 1, 2 and 3. For detection of 
Campylobacter species the samples were incubated for 3 
days at 42°C in a microaerophilic environment with the use 
of Campylobacter medium. For detection of E. coli 0157, 
the samples were incubated for 3 days at 37°C on sorbitol 
MacConkey agar. These tests were carried out at the local 
Microbiology Department.
Samples were tested for rotavirus by the use of ELISA at 
the local Virology Department and for Norovirus by use of 
reverse transcription-polymerase chain reaction (RT/PCR) at 
ISS in Rome. 
Stools suspensions (10%) were used for viral RNA extraction 
with the commercial QIAmp® Viral RNA Mini Kit (Qiagen, 
Hilden, Germany) according to the manufacturer’s instructions. 
This kit provides rapid DNA purification from fresh or frozen 
human stool or other sample types that have high concentrations 
of PCR inhibitors. The RNAs obtained were examined by a NoV-
specific reverse transcription-polymerase chain reaction (RT-
PCR) using the primers JV12-JV13 targeting a 327 bp nucleotide 
region of the open reading frame (ORF) 1 (RdRp). To confirm 
diagnosis and to characterise strains, a number of NoV positive 
samples were subjected to nucleotide sequencing of the ORF1 
fragment, perfomed using ABI PRISM BigDye Terminator kit 
version 2.0 (Applied Biosystems). The sequences corresponding 
to the ORF1 region were aligned with those present in the FBVE 
(FoodBorne Viruses in Europe; QLK1-CT-1999-00594) Data 
Bank and analysed using DNASIS Max software (Hitachisoft). 
Samples were analysed for intestinal parasites by means of 
microscopic examination of fixated samples.
The study was approved by the University of Malta Research 
Ethics Committee.
Results
A total of 3513 persons were contacted over a 21-month 
period from April 2004 to December 2005.  Of the persons 
with whom telephone communication was made at any point 
in time, 3504 participated, giving a response rate of 99.7%. Of 
these, a total of 99 respondents met the definition of IID cases 
resulting in a standardised monthly prevalence of 3.18% [95% 
CI 0.7%-5.74%] with 0.421 [95% CI 0.092-0.771] episodes of 
IID per person per year.  
The 99 cases were asked by the investigators to submit stool 
samples for analysis but only 37 (37.4%) submitted stools.  No 
vomitus samples were submitted.  Specimens were received 
between 4 and 33 days after the first onset of symptoms with 
a median of 18.76 days. There was no significant difference 
(p=0.92) between the lag-time from onset to submission in the 
samples that tested positive to those testing negative (20.5:19.9 
days). Univariate analysis for association of submission of stool 
samples with age group, duration of symptoms, health care 
provider seeking and hospitalisation showed no significance 
with p=0.082, 0.356, 0.102, 0.618 respectively. Hence it seems 
that these factors did not seem to affect submission of stools for 
analysis. Figure 3 shows the percentage of cases who submitted 
stools and had a positive culture according to the duration of 
illness.  None of the cases who had ongoing symptoms at the 
time of interview had a positive stool culture. 
All the samples were sufficient for analysis for bacteria and 
protozoa (n=37) whilst 30 samples were analysed for rotavirus 
and 30 samples for norovirus. Of those cases who submitted 
stools, Salmonella goldcoast was identified in one case (2.7% of 
those analysed), rotavirus in three cases (10% of those analysed) 
and norovirus in six cases (20% of those analysed). Of the six 
positive cases for norovirus, one was GI.2 (Southampton) and 
another was GII.4 Lordsdale genotypes (Table 3). 
The ages of the cases with positive samples varied by 
pathogen. A 64-year-old had double pathology with Salmonella 
goldcoast and norovirus. Another case, aged 59 years, had 
double pathology with rotavirus and norovirus.  The other 
two rotavirus cases were aged 58 and 64 years and the other 
norovirus cases were aged 1, 10, 39 and 78 years.  Figure 4 
shows the age distribution of the cases compared to the ones 
who submitted stools and those having a positive result. 
Discussion
This was the first community-based study to identify 
the different aetiological pathogens for IID in Malta. Most 
international studies attempting to identify aetiological agents 
were prospective cohort studies,5,12 however these are expensive 
and time consuming.  This study has attempted to recruit 
participants from a retrospective study in order to identify the 
aetiological agents implicated. The advantages of such a study 
are that it is less expensive, less time consuming and does not 
suffer from loss to follow up which are common problems 
in cohort studies. However, retrospective studies have other 
disadvantages in attempting to identify aetiological agents 
which include non compliance bias and difficulty in isolation 
of pathogens due to the time lag in submitting specimens. The 
latter may lead to the identification of persistent organisms 
and hence may not reflect the overall pattern in aetiology. 
In international studies identifying pathogens of IID, the 
predominant pathogen at community level was norovirus 
with rates of 7 to 11%4,5 and Campylobacter at GP level with 
rates of 10.4 to 13%.6,8,12 Similarly, despite the low response 
rate in submitting samples for analysis in the described study 
in Malta, the majority of cases were positive for norovirus. 
Norovirus is one of the human caliciviruses that have a 
worldwide distribution and has no seasonal incidence except 
for an apparent predominance in winter. It is the major cause 
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Figure 3: Number of cases who submitted stools and those tested postive by duration of illness
of epidemic gastroenteritis in both developed and developing 
countries.16 The disease is usually mild and self-limiting and 
occurs mainly in family or community-wide outbreaks, affecting 
adults, school children, family contacts and young children.17 
Rotavirus is the target organism most frequently identified 
in children up to the age of five years in both industrialised and 
developing countries.18 A WHO-sponsored review of rotavirus 
studies found that 20–70% of all hospitalisations and 20% 
of deaths from diarrhoea in children were attributable to 
rotavirus.19 Studies have estimated that 500,000 to 600,000 
children die each year because of rotavirus gastroenteritis.20-25 
The cases identified in the current study were aged more than 
50 years. However, the numbers identified were small and not 
representative.  
Salmonella goldcoast is only occasionally observed in 
Malta. From the local national surveillance system, there were 
no other cases of this serotype in the same year of study.  The 
main Salmonella infections seen in Malta are similar to those 
found in other countries where Salmonella enteritidis is the 
commonest species and Salmonella typhimurium is the second 
largest serotype.3 The prevalence of Salmonella is usually higher 
in the 0-4 year age group26 although this was not seen in our 
study. Similarly other pathogens that are frequently identified 
from community studies and from national surveillance systems, 
for example Campylobacter, were not isolated.  
A large number of samples from the study were negative 
for the pathogens tested. There are several possible reasons for 
this. There are some organisms that are known from studies 
elsewhere to cause IID, but were not tested for in this study. 
These include Bacillus spp., Clostridium difficile, Clostridium 
perfringes, Listeria, Vibrio, Yersinia, adenovirus and others. 
The absence of pathogens in stool samples that were tested 
for can be related to the time the sample was taken from the 
onset of illness. The lag time from onset of symptoms to testing 
was long and this is known to affect the outcome of the result. 
Cases could have recovered from their illness at the time of 
the interview and so the pathogen may no longer have been 
present in the stools.27 Prior antibiotic usage could also lead 
Table 3: Aetiological agents identified from 









Salmonella 37 1 2.70
Campylobacter 37 0 -
E. coli 37 0 -
Shigella 37 0 -
Ova and Parasites 30 0 -
Rotavirus 30 3 10
Norovirus 30 6 20
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to a negative result. Non-infective causes of intestinal disease 
can cause symptoms which are very similar to those of IID but 
the case definition used in the study sought to exclude these 
cases. Another explanation for negative results could be the low 
sensitivity of certain methods of detection.  
The main limitation in this study was the cooperation rate 
in the submission of samples.  A number of factors could have 
contributed to this: the patient may have felt better and did 
not feel the need to comply, the inconvenience of collecting 
the sample and of delivering it to the laboratory or health 
centre and the physical inability to collect the sample due to 
constipation. One major limitation inherent in cross-sectional 
studies like this is that, for some of the cases, their illness 
would have resolved by the time of interview and hence there 
would be lower excretion of pathogens in faeces, which would 
limit the identification. Another factor is patient compliance 
since, as mentioned previously, the cases may think that it is 
not important to perform the test once the illness has resolved. 
This limitation may be responsible for some of the differences 
in pathogens identified at various levels of the referral system. 
Cross sectional studies in other countries including Australia, 
Canada and Ireland have not attempted to perform analysis on 
stool samples so no comparison can be made with these. Malta 
is a small country with a population of about 400,000 persons so 
one would expect small numbers of persons taking samples for 
analysis. One option for a higher compliance rate is to perform 
cohort studies where cases are picked up early in the course of 
Figure 4: Number of cases who submitted stools and those tested postive by age group
illness, as conducted in the UK4,9 and Netherlands5,6 studies. 
However, such studies are very expensive and time consuming. 
Another option is to perform a study on the seroepidemiology 
of various enteric pathogens.28 However, the use of such studies 
in determining disease incidence must be viewed with caution 
since they do not differentiate between infection and disease. 
Hence the approach of stool sample analysis was performed, 
not withstanding the deficiencies encountered.
Despite the limitations of this study in sample size it has 
described norovirus as being the commonest aetiological cause 
of IID in the community of Malta, which along with the data 
from the national surveillance system would be beneficial in 
planning policies for the control of infectious intestinal disease. 
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